Mallinckrodt Defends Price Hike As Necessary To Save Drug
Mallinckrodt has urged a California federal judge to toss Humana's $700 million price-gouging lawsuit over an infant seizure syndrome treatment, arguing that the insurer cannot rely on settlements with federal antitrust...To view the full article, register now.
Already a subscriber? Click here to view full article